ConductScience.org, home

Paper40685652

Androgen receptor expression in triple negative breast cancer: an Algerian population study.

Hedjem A and 10 others. Libyan J Med, 2025. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Androgen receptor expression in triple negative breast cancer: an Algerian population study. Papers, record 40685652. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40685652

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Androgen receptor expression in triple negative breast cancer: an Algerian population study.
PubMed
Journal
Libyan J Med
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-01-23
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hedjem AAmel
2Kouchkar AAmal
3Ladjeroud AAmel
4Zerrouki NNacera
5Benaissa FFatima
6Ibrahim NANasir A
7Aleissa MSMohammed Saad
8Basher NSNosiba S
9Derguini AAssia
10Idres TTakfarinas
11Houali KKarim

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Receptors, AndrogenMajor topic
Triple Negative Breast NeoplasmsMajor topic
Humans
Female
Middle Aged
Algeria
Adult
Aged
Biomarkers, Tumor
Survival Rate
Ki-67 Antigen

Source PubMed

Download CSV of topics

References42

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
124978437Androgen receptor expression in early triple-negative breast cancer: clinical significance and prognostic associations.Cancers (Basel)2014https://conductscience.org/library/papers/24978437PubMed
216938528Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes.Hum Pathol2006https://conductscience.org/library/papers/16938528PubMed
320586616
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version).
Arch Pathol Lab Med2010https://conductscience.org/library/papers/20586616PubMed
423965901Phase II trial of bicalutamide in patients with androgen receptor-positive, estrogen receptor-negative metastatic Breast Cancer.Clin Cancer Res2013https://conductscience.org/library/papers/23965901PubMed
529327767Triple negative breast cancer: A clinico-epidemiological and histopronostic study of 90 cases.Tunis Med2017https://conductscience.org/library/papers/29327767PubMed
627426056Value of Ki-67 expression in triple-negative breast cancer before and after neoadjuvant chemotherapy with weekly paclitaxel plus carboplatin.Sci Rep2016https://conductscience.org/library/papers/27426056PubMed
719704069Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancer.J Clin Oncol2009https://conductscience.org/library/papers/19704069PubMed
828666920Neoadjuvant therapy for triple negative and HER2-positive early breast cancer.Breast2017https://conductscience.org/library/papers/28666920PubMed
921155040Clinicopathlogic and immunohistochemical characteristics of triple negative invasive lobular carcinoma.Yonsei Med J2011https://conductscience.org/library/papers/21155040PubMed
1021633166Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies.J Clin Invest2011https://conductscience.org/library/papers/21633166PubMed
1123031358Expression of androgen receptors in triple negative breast carcinomas.Acta Histochem2013https://conductscience.org/library/papers/23031358PubMed
1220593180Predictive factors for the effectiveness of neoadjuvant chemotherapy and prognosis in triple-negative breast cancer patients.Cancer Chemother Pharmacol2011https://conductscience.org/library/papers/20593180PubMed
1318507821Androgen receptor expresion in breast cancer: relationship with clinicopathological characteristics of the tumors, prognosis, and expression of metalloproteases and their inhibitors.BMC Cancer2008https://conductscience.org/library/papers/18507821PubMed
1421240988Expression of nuclear receptor DAX-1 and androgen receptor in human breast cancer.J Surg Oncol2011https://conductscience.org/library/papers/21240988PubMed
1525536589Outcome of 561 non-metastatic triple negative breast cancer patients: multi-center experience from Turkey.J BUON2014https://conductscience.org/library/papers/25536589PubMed
1618657139Impact of triple negative phenotype on breast cancer prognosis.Breast J2008https://conductscience.org/library/papers/18657139PubMed
1723373898Androgenic pathway in triple negative invasive ductal tumors: its correlation with tumor cell proliferation.Cancer Sci2013https://conductscience.org/library/papers/23373898PubMed
1824101045Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.J Clin Oncol2013https://conductscience.org/library/papers/24101045PubMed
1923392436Comparison of basal-like triple-negative breast cancer defined by morphology, immunohistochemistry and transcriptional profiles.Mod Pathol2013https://conductscience.org/library/papers/23392436PubMed
2018171422Triple negative tumours: a critical review.Histopathology2008https://conductscience.org/library/papers/18171422PubMed

See all 42 referencesDownload CSV of references

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AR367PubTator's text mininghttps://conductscience.org/library/genes/367NCBI Gene
ERBB22064PubTator's text mininghttps://conductscience.org/library/genes/2064NCBI Gene
PTPRF5792PubTator's text mininghttps://conductscience.org/library/genes/5792NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40685652

GET https://conductscience.org/api/papers/v1/40685652/references?page=2